TIME SESSION TITLE ROOM

Size: px
Start display at page:

Download "TIME SESSION TITLE ROOM"

Transcription

1 TRACKS Basic Science Translational Science Clinical Science Population Science Scientific Sessions integrates four broad areas of basic, translational, clinical and population sciences into its more than 5,000 presentations. To assist you in navigating the meeting, Scientific Sessions offers 26 program tracks. These tracks allow you to focus your education in your specialty or expand your knowledge in other areas. TRACK ACUTE CORONARY SYNDROME ATHEROSCLEROSIS AND THROMBOSIS CARDIAC STRUCTURE AND FUNCTION CARDIOPULMONARY RESUSCITATION CARDIOVASCULAR AND STROKE NURSING CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENT CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPAN DIABETES, LIPIDS AND CARDIOMETABOLIC SYNDROME EARLY CAREER/PROFESSIONAL DEVELOPMENT ELECTROPHYSIOLOGY GENERAL CARDIOLOGY AND STRUCTURAL HEART DISEASE GENETICS/GENOMICS GLOBAL CONGRESS ON PHYSICAL ACTIVITY HEART FAILURE HYPERTENSION AND KIDNEY DISEASE IMAGING INTERVENTIONAL CARDIOLOGY MYOCYTE SIGNALING AND ION CHANNELS PERIPHERAL VASCULAR DISEASE PHARMACOLOGY PREVENTION, BEHAVIOR CHANGE AND HEALTHY LIFESTYLES PULMONARY & SYSTEMIC VASCULAR BIOLOGY AND DISEASE QUALITY OF CARE OUTCOMES AND EPIDEMIOLOGY STROKE AND CEREBROVASCULAR DISEASE SURGERY SYSTEMS BIOLOGY/PHYSIOLOGY, INCLUDING OMICS Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth 339

2 ACUTE CORONARY SYNDROME Sunday Nov 17 8:00-9:30 SMP.602 Reperfusion Strategies for STEMI: Around the World Room D226 8:00-11:00 SMP.702 Is It Time to Think Bigger About Microvascular Disease in the Heart? Room C146 9:00-5:00 APS Clinical and Hospital-Based Observational Studies Hall F, Core 2 APS Markers for Prognosis in CVD I Hall F, Core 2 APS Myocardial Infarction: Novel Mechanisms of Injury and Repair Hall F, Core 7 APS Novel Insights into the Management of ACS: Quality of Care and Outcomes Hall F, Core 7 APS Novel Therapeutic Strategies and Approaches to Risk Stratification for Patients with ACS Hall F, Core 7 APS Risk Factors I Hall F, Core 7 APS Risk Factors, Mortality and Mechanisms of Atherosclerosis Hall F, Core 7 APS Role of Macrophages and Other Leukocytes in Atherosclerosis Hall F, Core 7 APS Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Hall F, Core 7 9:30-11:00 SMP.603 Interventional Cardiology: The Best Trials of 2013 Room D226 4:00-5:19 LBCT.01 Acute Cardiovascular and Cerebrovascular Care Hall E 5:30-6:45 CVS.729 Joint AHA/Oman Heart Association Session: Reperfusion in STEMI Achievements and Challenges Monday Nov 18 Room D227 9:00-11:55 AOS Still the One: Population Burden and Trends of CVD Room D162 9:00-12:00 AOS F Optimizing Stem Cell Repair in Models of Disease Room C146 AOS N Sol Sherry Distinguished Lecture in Thrombosis and Treatment of Thrombotic Disease Room C140 9:00-12:10 AOS Acute Coronary Syndrome Care and Complications: Quality Care and Outcomes Room C143 AOS Cardiometabolic Effects of Popular Diets Room D167 9:00-5:00 APS Atherogenesis and Myocardial Injury Hall F, Core 7 APS Catheter-Based Coronary Imaging and Hemodynamics III Hall F, Core 6 APS Clinical and Hospital-Based Observational Studies: Acute Coronary Syndrome and Percutaneous Coronary Intervention Hall F, Core 2 APS Coronary Interventions: Risky Patients and Risky Lesions Hall F, Core 6 APS From Genomic Target to Disease Mechanism Hall F, Core 3 APS Hyperhomocysteinemia and Vascular Reactivity Hall F, Core 7 APS Improving Care in ACS, PCI and Cardiovascular Surgery Hall F, Core 2 APS Ischemic Heart Disease: Diagnosis and Prognosis Hall F, Core 7 APS Markers for Prognosis in CVD II Hall F, Core 2 APS Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7 APS Novel Mechanisms and Therapeutics in Angiogenesis Part I Hall F, Core 7 APS h Risk Factors and Systemic Mediators of Atherosclerosis Hall F, Core 7 APS Risk Factors II Hall F, Core 7 APS Role of Smooth Muscle Cells and Endothelium in Atherosclerosis Hall F, Core 7 APS Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy Hall F, Core 7 2:00-3:15 CVS.606 Primary PCI: State of the Art Room D226 2:00-4:55 AOS Proliferation, Remodeling, Extracellular Matrix I Room C146 2:00-5:10 AOS Risk Factors Room C144 AOS Surgical Revascularization for Ischemic Heart Disease I Room D227 AOS Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Room C140 3:45-5:13 LBCT.04 Therapeutic Advances in Coronary and Peripheral Vascular Disease Ballrooms C1&C2 70 Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

3 ACUTE CORONARY SYNDROME (cont.) 5:30-6:45 CVS.407 Impact of Medical Gases on Ischemia-Reperfusion and Cardiac Arrest Outcomes Hall B-2 Tuesday Nov 19 7:30-8:45 CVS.108 In Search of the Culprit Lesion: Utility of Imaging Elm Fork Room 9:00-12:10 AOS CT Imaging of Coronary Atherosclerosis Clear Fork Room AOS N Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non ST-Elevation ACS Room C143 AOS Novel Approaches and Technologies in AMI and Coronary Intervention Room D223 AOS Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure Hall B-5 AOS Physical Activity/Exercise Benefits: From Childhood to End-Stage Disease Room D163 9:00-5:00 APS Biomarkers Hall F, Core 7 APS Catheter-Based Coronary Interventions: Technologies and Outcomes Hall F, Core 6 APS Clinical and Hospital-Based Observational Studies: CVD Risk Factors Hall F, Core 2 APS Diabetes Mellitus and CVD: Clinical Outcomes Hall F, Core 2 APS Diabetes Mellitus and CVD: Clinical Studies and Interventional Cardiology Hall F, Core 2 APS h Ischemic Heart Disease: Treatment and Mechanisms Hall F, Core 7 APS Lipoproteins and Systemic Regulation of Atherosclerosis Hall F, Core 7 APS Markers for Prognosis in CVD III Hall F, Core 2 APS Mechanisms of Coagulation and Thrombosis Hall F, Core 7 APS h Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7 APS New Concepts in Platelet Function Hall F, Core 7 APS Novel Mechanisms and Therapeutics in Angiogenesis Part II Hall F, Core 7 APS Proliferation, Remodeling, Extracellular Matrix II Hall F, Core 7 APS Systems of Care and Prognostic Indicators for Acute ST-Elevation Myocardial Infarction Hall F, Core 7 APS The Spectrum of PCI: From Acute Coronary Syndromes to Chronic Occlusions Hall F, Core 6 APS Translational and Clinical Studies of Cardiovascular Stem Cells Hall F, Core 7 2:00-5:00 AOS N Russell Ross Memorial Lectureship in Vascular Biology and Mechanisms of Atherosclerosis Room C143 2:00-5:10 AOS Novel Insights into CVD Treatments and Outcomes from Observational Studies Room D163 5:30-6:45 CVS.619 Joint AHA/Caribbean Cardiac Society Joint Session: Barriers to Adoption of New Pharmacologies in ACS Management US and International Perspectives Room D222 Wednesday Nov 20 7:30-8:45 CVS.725 Depression: Status as a Risk Factor in Acute Coronary Syndromes Room C144 ATE.104 Extreme Imaging Elm Fork Room CVS.225 Joint AHA/Mexican Society of Cardiology: Looking South in Cardiovascular Disease Room D162 9:00-12:00 APS h Biomarkers in Cardiac Disease and Diabetes Hall F, Core 7 APS Gene Regulation and Soluble Mediators of Atherosclerosis Hall F, Core 7 APS Hemostasis, Thrombosis and Coagulation Hall F, Core 7 APS Markers for Prognosis in CVD IV Hall F, Core 2 APS Surgical Revascularization for Ischemic Heart Disease III Hall F, Core 6 9:00-12:10 AOS Noncoronary Vascular Imaging Clear Fork Room 10:45-12:15 CS.04 Advanced Cardiovascular Disease: Complications and Challenges Ballrooms C1&C2 Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

4 ATHEROSCLEROSIS AND THROMBOSIS Sunday Nov 17 8:00-11:00 SMP.205 Clinical Lipidology: Controversies in Cardiovascular Risk Reduction Room D167 SMP.702 Is It Time to Think Bigger About Microvascular Disease in the Heart? Room C146 SMP.302 Looking into a Crystal Ball: The Future of Genetics and Genomics Ballroom A2 SMP.201 New Scientific Advances That Support Food-Based Dietary Recommendations Room D162 SMP.202 Novel Therapeutics and Strategies in Type 2 Diabetes and CVD Room D170 SMP.704 Obesity in CVD Room C140 SMP.701 SMP.701 The Inflammasome Pathway in Cardiovascular and Metabolic Disease Basic Science to Clinical Trials The Inflammasome Pathway in Cardiovascular and Metabolic Disease Basic Science to Clinical Trials Room C144 Room C144 SMP.801 Groundbreaking Studies in the Practice of Cardiovascular Medicine: Circulation Editors' Choices Room D227 9:00-5:00 APS Catheter-Based Coronary Imaging and Hemodynamics I Hall F, Core 6 APS Catheter-Based Coronary Imaging and Hemodynamics II Hall F, Core 6 APS Claudication, Aortoiliac Disease, Ankle Brachial Index Hall F, Core 6 APS Clinical Nuclear Cardiology: Expanding Evidence and Applications Hall F, Core 1 APS Clinical Nuclear Cardiology: Expanding Evidence and Applications Hall F, Core 1 APS Controlling and Observing Stem Cell Behavior Hall F, Core 7 APS CT Imaging of Coronary Atherosclerosis II Hall F, Core 1 APS Femoropopliteal Artery Stenting; Restenosis Hall F, Core 7 APS Lipoprotein Metabolism: Clinical and Population Studies Hall F, Core 2 APS Mechanisms and Regulation of Hepatic Lipid Metabolism Hall F, Core 2 APS Mechanisms of Brain Injury and Protection Hall F, Core 7 APS Novel Therapeutic Strategies and Approaches to Risk Stratification for Patients with ACS Hall F, Core 7 APS Oxidative Stress and Endothelial Function Hall F, Core 7 APS Regulation of Gene Expression in the Vascular System Hall F, Core 3 APS Remodeling, Extracellular Matrix, Aortic Disease Hall F, Core 7 APS Risk Factors I Hall F, Core 7 APS Risk Factors, Mortality and Mechanisms of Atherosclerosis Hall F, Core 7 APS Role of Macrophages and Other Leukocytes in Atherosclerosis Hall F, Core 7 APS Targeted Modulation of Lipid Metabolism Hall F, Core 2 APS Translational Molecular Imaging: Novel Probes and Advanced Clinical Applications Hall F, Core 1 APS Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Hall F, Core 7 3:45-5:00 SS.01 Best of AHA Specialty Conferences Room C147 AOS Y ATVB Early Career Investigator Award Finalists Room C140 5:30-6:45 CVS.203 Brown Adipose Tissue: Its Renaissance and Relevance to Cardiovascular Health Room D163 CVS.705 Hard Issues on Soft Tissues: Contributing Cells in Vascular Calcification Room C144 CVS.204 Joint AHA/International Atherosclerosis Society Session: Should HDL Be a Target? Room D167 CVS.701 Latest Advances in Oxidative Stress Mechanisms of Metabolic Diseases Room C146 CVS.703 Leukocytes as Drivers of Atherosclerosis: Recent Advances Room C140 CVS.702 Mechanisms and Obstacles in Removal of Cholesterol from Atherosclerotic Plaques Room C150 CVS.101 State of the Art in Cardiac Computed Tomography Elm Fork Room 72 Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

5 ATHEROSCLEROSIS AND THROMBOSIS (cont.) Monday Nov 18 7:30-8:45 CVS.706 Inflammation, Immunity and Hypertension Room C150 CVS.707 Maintaining Hemostasis on Antithrombotic Therapy Room C146 CVS.206 Pathway-Selective Insulin Resistance and Cardiovascular Complications: How High Levels of Insulin Can Cause Harm Room D163 9:00-12:00 AOS F Emerging Role of PET Biomarkers in Cardiovascular Disease West Fork Room AOS F Optimizing Stem Cell Repair in Models of Disease Room C146 9:00-12:00 AOS N Sol Sherry Distinguished Lecture in Thrombosis and Treatment of Thrombotic Disease Room C140 AOS Acute Coronary Syndrome Care and Complications: Quality Care and Outcomes Room C143 AOS Cardiac MR Imaging I Clear Fork Room AOS Cholesterol Homeostasis: PCSK9 and Reverse Cholesterol Transport Room D163 9:00-5:00 APS Aortic and Peripheral Vascular Disease; Pulmonary Embolism Hall F, Core 6 APS Atherogenesis and Myocardial Injury Hall F, Core 7 BASC.03 Best of AHA Specialty Conferences: ATVB 2013 Hall F APS Catheter-Based Coronary Imaging and Hemodynamics III Hall F, Core 6 APS Chronic Coronary Artery Disease: Quality of Care and Outcomes Hall F, Core 7 APS Diabetes Mellitus and CVD: Clinical Studies Hall F, Core 2 APS Dyslipidemia and Treatment Hall F, Core 2 APS Familial Hypercholesterolemia and Other Lipid Disorders Hall F, Core 2 APS Genetic Variation and Coronary Artery Disease Hall F, Core 3 APS Hyperhomocysteinemia and Vascular Reactivity Hall F, Core 7 APS Ischemic Heart Disease: Diagnosis and Prognosis Hall F, Core 7 APS Lipids and Multimarkers Hall F, Core 2 APS Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7 APS New Insights into Lipoprotein Metabolism Hall F, Core 2 APS Nitric Oxide and Endothelial Function Hall F, Core 7 APS Novel Mechanisms and Therapeutics in Angiogenesis Part I Hall F, Core 7 APS Redox Signaling and Oxidative Stress Hall F, Core 7 APS h Risk Factors and Systemic Mediators of Atherosclerosis Hall F, Core 7 APS Risk Factors II Hall F, Core 7 APS Role of Smooth Muscle Cells and Endothelium in Atherosclerosis Hall F, Core 7 APS h Stem Cells and Tissue Engineering for Regeneration Hall F, Core 7 APS Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy Hall F, Core 7 2:00-4:55 AOS Proliferation, Remodeling, Extracellular Matrix I Room C146 2:00-5:00 AOS F Common and Rare Variants Associated with CAD and Risk Factors Ballroom A2 AOS N George L. Duff Memorial Lecture and Therapeutic Approaches for Treating Dyslipidemias Room D167 AOS Cardiac MR Imaging II West Fork Room AOS New Concepts in the Regulation of Vascular Endothelial Function Room C143 AOS New Developments in Myocardial Pathology and Disease Hall B-9 AOS Risk Factors Room C144 AOS Thoracic Aortic Disease I Room D222 AOS Treatment Decisions for Coronary Artery Disease: Quality of Care and Outcomes Room D163 AOS Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Room C140 AOS Vulnerable Plaque, Drug-Eluting Stents: Insights from Advanced Coronary Imaging and Physiology Room D223 3:45-5:00 PS.04 Novel Oral Anticoagulants: Clinical Conundra Hall E Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

6 ATHEROSCLEROSIS AND THROMBOSIS (cont.) 5:30-6:45 CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150 Tuesday Nov 19 CVS.212 Lowering ApoB-Containing Lipoproteins: Diversity of Therapeutic Targets Room D167 CVS.210 Racial/Ethnic Differences in Risks for Diabetes and Heart Disease: Implications for Diagnosis and Management Room D163 7:30-8:45 CVS.716 Crosstalk Between Oxidation and Inflammation in Vascular Disease Room C144 CVS.718 Incretin Hormones in CVD: New Kids on the Block Room C143 CVS.216 Lipid Metabolism in Cardiometabolic Syndrome and Atherogenesis Room D163 CVS.409 Management of Anticoagulation and Antiplatelet Agents at the Time of Device Procedure Hall B-3 CVS.717 Omega-3 Fatty Acids, Cardiovascular Health and Controversy Room C140 9:00-12:00 AOS N Ancel Keys Memorial Lecture and Subclinical Atherosclerosis and Cardiovascular Risk Room D167 AOS CT Imaging of Coronary Atherosclerosis Clear Fork Room AOS Dilemmas in the Anticoagulation of Atrial Fibrillation Hall B-1 AOS N Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non ST-Elevation ACS Room C143 AOS Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease Ballroom A2 AOS Novel Approaches and Technologies in AMI and Coronary Intervention Room D223 AOS Optimizing Ways to Detect and Treat Ischemic Heart Disease Room C140 AOS Peripheral Arterial Disease, Myopathy, Lipid and Cellular Modulation Room C144 9:00-5:00 APS Biomarkers Hall F, Core 7 APS Biomarkers, Lipoprotein Metabolism and CVD Hall F, Core 2 APS Diabetes Mellitus and CVD: Clinical Outcomes Hall F, Core 2 APS Diabetes Mellitus and CVD: Clinical Studies and Interventional Cardiology Hall F, Core 2 APS Genetics of Lipids, Insulin Resistance and CAD Hall F, Core 3 APS Growth Factors, Cytokines, Signal Transduction Hall F, Core 7 APS Inflammation and Adhesion Molecules I Hall F, Core 7 APS Insights from Omic Profiling of Cardiovascular Disease Hall F, Core 3 APS h Ischemic Heart Disease: Treatment and Mechanisms Hall F, Core 7 APS Lipoproteins and Systemic Regulation of Atherosclerosis Hall F, Core 7 APS Mechanisms of Coagulation and Thrombosis Hall F, Core 7 APS h Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7 APS New Concepts in Platelet Function Hall F, Core 7 APS New Insights into Myocardial Structure and Pathology Hall F, Core 5 APS Novel Mechanisms and Therapeutics in Angiogenesis Part II Hall F, Core 7 APS Novel Signaling Pathways in the Regulation of Endothelial Function Hall F, Core 7 APS Peripheral Vascular Disease: Critical Limb Ischemia Hall F, Core 7 APS Proliferation, Remodeling, Extracellular Matrix II Hall F, Core 7 APS The Spectrum of PCI: From Acute Coronary Syndromes to Chronic Occlusions Hall F, Core 6 APS Treatment of Dyslipidemias Hall F, Core 2 APS Vascular Pathology and CVD Outcomes Hall F, Core 2 2:00-5:00 AOS N Russell Ross Memorial Lectureship in Vascular Biology and Mechanisms of Atherosclerosis Room C143 2:00-5:10 AOS Cardiovascular Biomarkers Room C140 AOS Case Studies: Finding a Needle in a Haystack Room D Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

7 ATHEROSCLEROSIS AND THROMBOSIS (cont.) 5:30-6:45 ATE.702 Are Cholesterol-Loaded Macrophages Proinflammatory? Room C143 CVS.220 Dietary Management of Obesity and CVD Risk Factors: New Paradigms? Room D170 CVS.723 How Are Mechanisms of Arteriogenesis Affected by Metabolic Syndrome and Diabetes? Room C144 CVS.722 Lipid-Based Signaling Molecules and Their Receptors in Thrombosis and Vascular Biology Room C140 CVS.221 Mechanisms Regulating Hepatic VLDL Assembly and Secretion Room D163 Wednesday Nov 20 7:30-8:45 CVS.724 A2-Type Adenosine Receptors Revisited in Control of Metabolic and Vascular Disease Room C143 ATE.105 How to Image Vessel Wall and Atherosclerosis West Fork Room CVS.525 Inflammation in Cardiac Disease and Remodeling Hall B-9 CVS.726 New Concepts in Arterial Stiffening and Hypertension Room C140 CVS.223 Obesity, Ectopic Fat and Cardiometabolic Risk: It's Not How Much You Have But Where You Put It Room D163 9:00-10:15 SS.15 The Legacy of Cardiovascular Disease for Cancer Survivors Room C147 9:00-12:00 APS Aneurysmal Disease; Vasculopathies Hall F, Core 7 APS Cellular Therapies for Heart Failure and Transplant Vasculopathy Hall F, Core 6 APS Echocardiography and Coronary Artery Disease Hall F, Core 1 APS Gene Regulation and Soluble Mediators of Atherosclerosis Hall F, Core 7 APS Hemostasis, Thrombosis and Coagulation Hall F, Core 7 APS Inflammation and Adhesion Molecules II Hall F, Core 7 APS Noncoronary Vascular Imaging I Hall F, Core 1 APS Noncoronary Vascular Imaging II Hall F, Core 1 APS Peripheral Vascular Disease: Metabolic Disorders Hall F, Core 7 APS Recent Advances in the Regulation of Vascular Endothelial Function Hall F, Core 7 APS Subclinical CVD Imaging II Hall F, Core 2 9:00-12:10 AOS Molecular Signals in Vascular Development and Disease Room C146 AOS Noncoronary Vascular Imaging Clear Fork Room AOS Renovascular and Cerebrovascular Disease; Hypertension Room D223 AOS Vascular Inflammation and Adhesion Receptors Room C144 CARDIAC STRUCTURE AND FUNCTION Saturday Nov 16 1:00-2:40 EC.11 Mission Possible: Keys to Early Career Academic Success Part 1 (Planned by the Council on Basic Room C143 Cardiovascular Sciences) 3:00-4:45 EC.16 Mission Possible: Keys to Early Career Academic Success Part 2 (Planned by the Council on Basic Room C143 Cardiovascular Sciences) Sunday Nov 17 8:00-11:00 SMP.401 Arrhythmogenic and Hypertrophic Cardiomyopathies: Scientific and Clinical Updates Hall B-4 SMP.503 Epigenetics of Cardiac Development and Disease Hall B-6 SMP.101 Myocardial Bioenergetics in Heart Failure West Fork Room SMP.502 Stem Cell Therapeutics Hall B-5 SMP.801 Groundbreaking Studies in the Practice of Cardiovascular Medicine: Circulation Editors' Choices Room D227 SMP.501 The DeHaan Cardiac Myogenesis Initiative Room D223 9:00-5:00 APS Cancer and Cardiovascular Disease I Hall F, Core 2 APS h Cardioprotection: Mechanisms of Ischemia-Reperfusion Injury Hall F, Core 5 APS Cardioprotection: Translation and Clinical Implications Hall F, Core 5 APS Cardioprotection: Focus on Mitochondria Hall F, Core 5 Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

8 CARDIAC STRUCTURE AND FUNCTION (cont.) 9:00-5:00 APS Cation Regulation Disorders and Heart Failure Hall F, Core 5 APS Cell and Tissue Engineering Therapies for Heart Failure Hall F, Core 5 APS Contractile Proteins and Key Signaling Molecules in Heart Failure Hall F, Core 5 APS CT Imaging of Coronary Atherosclerosis I Hall F, Core 1 APS Diabetes Mellitus and CVD: Basic Studies Hall F, Core 2 APS Echocardiography in Diagnosis and Prognosis Hall F, Core 1 APS Echocardiography: Right-Heart Function and Pressures Hall F, Core 1 APS Epidemiology of Heart Failure Hall F, Core 2 APS Extracellular Matrix Proteins and Cardiac Remodeling Hall F, Core 5 APS h Imaging and Outcomes in Valvular Heart Disease Hall F, Core 5 APS Imaging Myocardial Mechanics Hall F, Core 1 APS Metabolic Disorder and Cardiac Hypertrophy Hall F, Core 5 APS Myocardial Infarction: Novel Mechanisms of Injury and Repair Hall F, Core 7 APS Myopathic and Pericardial Disease: From Bench to Bedside Hall F, Core 5 APS Novel Angiogenic and Regenerative Therapies for Heart Failure Hall F, Core 5 APS Obesity in CVD Risk and Prevention: Basic Studies Hall F, Core 2 3:45-5:00 AOS Y Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators Finalists Hall B-5 5:15-6:30 AOS Y Melvin L. Marcus Young Investigator Award in Cardiovascular Sciences Finalists Hall B-5 5:30-6:45 CVS.501 Cardiac Fibroblasts Hall B-6 Monday Nov 18 CVS.502 Joint AHA/Progenitor Cell Biology Consortium Session: New Strategies for Myocardial Regeneration Clear Fork Room CVS.102 Seamless Networks of Myocardial Bioenergetics West Fork Room CVS.503 Systems Physiology of Cardiac Ischemia and Cell Death: New Molecular Regulators Room C147 7:30-8:45 CVS.508 Molecular Signaling in Cardiac Development and Diseases Hall B-8 9:00-11:27 CS.01 Application of Cell-Based Therapies to Treat Cardiac and Peripheral Diseases Ballroom A1 9:00-12:00 AOS F Echocardiography of Ventricular Structure and Function Elm Fork Room AOS N William W. L. Glenn Lecture and Surgical Therapy for Valvular Heart Disease II Room D227 9:00-12:10 AOS Cardiac MR Imaging I Clear Fork Room AOS Cardiometabolic Mechanisms in Heart Failure Hall B-6 AOS Cardioprotection: From Cellular Mechanisms to Ventricular Remodeling Hall B-8 AOS F New Developments in TAVR and Complex Structural Heart Interventions Room D223 9:00-5:00 APS h Biomarkers in Assessment of Changes in LV Function and Heart Failure: Role of Comorbidities, Filling Pressures and Heart Failure Status Hall F, Core 5 APS Cancer and Cardiovascular Disease II Hall F, Core 2 APS Cardiac Development and Myocardial Regeneration Hall F, Core 3 APS Clinical Aspects of Sarcoidosis and Various Cardiomyopathies Hall F, Core 5 APS CT Imaging for Prognosis Hall F, Core 1 APS Disease Prognosis by Cardiac MR Imaging I Hall F, Core 1 APS Disease Prognosis by Cardiac MR Imaging II Hall F, Core 1 APS Echocardiography: Clinical Applications of Myocardial Strain Imaging Hall F, Core 1 APS Echocardiography: Contrast Imaging and Myocardial Function Hall F, Core 1 APS Echocardiography: Right Ventricular Function and Mechanics Hall F, Core 1 APS Gene Regulatory Mechanisms in Heart Failure Hall F, Core 5 APS Immune and Inflammatory Mechanisms in Heart Failure Hall F, Core 5 APS Molecular and Cellular Mechanisms of Valvular Heart Disease Hall F, Core 5 76 Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

9 CARDIAC STRUCTURE AND FUNCTION (cont.) 9:00-5:00 APS Molecular Signaling in Cardiac Hypertrophy Hall F, Core 5 APS h Myocardial Energetics/Intermediary Metabolism I Hall F, Core 5 APS Noncoronary CT Imaging Hall F, Core 1 APS Novel Assessment of Diastolic Function Hall F, Core 1 APS Novel Cellular Therapies for Ischemic Heart Failure Hall F, Core 5 APS Pathophysiology and Patient Characteristics in Aortic Stenosis Hall F, Core 5 APS Subclinical CVD Imaging I Hall F, Core 2 APS Troponin, BNP and Other Biomarkers for CVD Risk Hall F, Core 2 BASC.05 Best of AHA Specialty Conferences: BCVS 2013 Hall F 12:40-1:40 SS.06 Lasker Awardee Lecture Hall E 2:00-5:10 AOS How to Assess and Improve Left Ventricular Function and Heart Failure: From Left Ventricular Mechanics and Arterial Compliance to Biomarkers Hall B-7 AOS Molecular Basis of Hypertrophy Hall B-6 AOS New Developments in Myocardial Pathology and Disease Hall B-9 2:00-5:15 LBS.01F Late-Breaking Basic Science and Featured Research Presentation Hall B-5 5:00-7:00 LBS.02 Late-Breaking Basic Science Posters and Reception Hall F APS Best of Basic Science Abstracts and Reception Hall F 5:30-6:45 CVS.513 Cardiomyocyte Renewal Hall B-5 Tuesday Nov 19 CVS.511 Dynamics of Protein Degradation Machinery in Cardiac Function Hall B-8 CVS.713 Emerging Paradigms in Progenitor Cell Therapy and Vascular Repair Room C143 CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150 CVS.512 The Emerging Roles of Cardiac Secretome: From Discovery to Mechanisms Hall B-9 7:30-8:45 CVS.516 Myofibrillar Proteins in Heart Failure Hall B-8 CVS.514 Novel Molecular Mechanisms of Mitochondrial Biology in the Heart Hall B-6 CVS.310 The Heart in the Muscular Dystrophies Ballroom A3 9:00-12:00 AOS N George E. Brown Memorial Lecture and Adult Stem Cells: Cardiac Homeostasis and Repair Hall B-7 9:00-12:10 AOS Fibroblast Modulation in Cardiac Remodeling Hall B-6 AOS Ventricular Function/Mechanics: Contractility and Biophysics Hall B-9 9:00-5:00 APS Calcium, Mitochondrial Remodeling and Mitophagy Hall F, Core 5 APS Cardioprotection: Remodeling, Heart Failure and Inflammation Hall F, Core 5 APS Exercise, Physical Activity, Rehabilitation and CVD Risk I Hall F, Core 2 APS Exercise, Physical Activity, Rehabilitation and CVD Risk II Hall F, Core 2 APS Hypertrophic Cardiomyopathy Clinical Science Hall F, Core 5 APS MR Characterization of Preclinical Disease Hall F, Core 1 APS MR Imaging for Fibrosis and Arrhythmias Hall F, Core 1 APS MR Imaging of Cardiac Structure Hall F, Core 1 APS Myocardial Energetics/Intermediary Metabolism II Hall F, Core 5 APS Novel Circulatory Biomarkers and Regulatory Proteins in Heart Failure Hall F, Core 5 APS Obesity in CVD Risk and Prevention: From Children to Adults Hall F, Core 2 APS Potpourri of Left Ventricular Function, Myocarditis and Pericarditis Hall F, Core 5 APS Receptor Pharmacology Hall F, Core 7 APS Tissue-Engineered and Cellular Therapies for Cardiomyopathy Hall F, Core 5 2:00-5:00 AOS N Charles T. Dotter Memorial Lecture and Noncoronary CT Topics Clear Fork Room 2:00-5:10 AOS Hypertrophic Cardiomyopathy: Novel Treatment and Outcomes Hall B-9 Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

10 CARDIAC STRUCTURE AND FUNCTION (cont.) 5:30-6:45 CVS.518 ips Cells in Cardiac Disease Modeling Hall B-8 Wednesday Nov 20 7:30-8:45 CVS.523 Cardiac-Based Gene Therapies Hall B-5 ATE.105 How to Image Vessel Wall and Atherosclerosis West Fork Room CVS.525 Inflammation in Cardiac Disease and Remodeling Hall B-9 CVS.728 Medical Management of Aneurysms: What Does the Evidence Show? Room C150 CVS.727 Rapid Nongenomic Mineralocorticoid Receptor Effects on Cardiovascular Function Room C146 CVS.524 Tissue Engineering Hall B-6 9:00-12:00 APS Cardioprotection: Pre-, Peri-, and Postconditioning Hall F, Core 5 APS Cardiorenal Physiology/Pathophysiology Part II Hall F, Core 7 APS Ventricular Function/Mechanics Hall F, Core 5 9:00-12:10 AOS Basic and Clinical Insights in Valvular Disease Hall B-7 AOS Markers of Myocardial Injury/Stress and Cardiovascular Risk Room D163 AOS Myocardial Energetics and Intermediary Metabolism in the Normal and Failing Heart Hall B-6 CARDIOPULMONARY RESUSCITATION Saturday Nov 16 1:00-1:45 EC.08 Cardiac Electrophysiology Sessions for AHA Early Career Day Part 1: Considering Electrophysiology Room D227 as a Specialty Sunday Nov 17 8:00-9:30 SMP.602 Reperfusion Strategies for STEMI: Around the World Room D226 8:00-11:00 SMP.402 Controversies in Hospital ECG Monitoring Hall B-3 SMP.703 Hypertensive Emergencies and Urgencies Room C150 9:00-5:00 APS Clinical and Hospital-Based Observational Studies Hall F, Core 2 3:45-5:00 AOS Y Cournand and Comroe Young Investigator Prize Finalists Hall B-1 4:00-5:19 LBCT.01 Acute Cardiovascular and Cerebrovascular Care Hall E 5:30-6:45 CVS.503 Systems Physiology of Cardiac Ischemia and Cell Death: New Molecular Regulators Room C147 Monday Nov 18 7:30-8:45 CVS.706 Inflammation, Immunity and Hypertension Room C150 ATE.402 Pro/Con: How Long Should We Continue Cardiac Arrest Resuscitation Efforts? Hall B-2 CVS.801 Strengthen the Chain: Improving Access to Acute Stroke Therapies Room D170 CVS.207 The Epidemic of Atrial Fibrillation: What's New for Non-EP Providers Room D168 9:00-12:10 AOS Cardiac Arrest: Epidemiology and Clinical Outcomes Hall B-2 AOS Fascinatin Rhythms: Epidemiology of Atrial Fibrillation and Sudden Death Room D170 9:00-5:00 APS Cardiac Arrest and Resuscitation: Mechanisms and Laboratory Studies Hall F, Core 4 APS Cardiac Arrest: Quality of Care and Educational Approaches Hall F, Core 4 2:00-3:15 CVS.405 Layperson and First Responder Approaches to Cardiac Arrest: Strengthening the Community Hall B-2 2:00-5:10 AOS Disorders of Pulmonary Circulation: Bench to Bedside Hall B-8 3:45-5:00 AOS N Dickinson W. Richards Lecture and Abstracts Hall B-2 5:30-6:45 CVS.407 Impact of Medical Gases on Ischemia-Reperfusion and Cardiac Arrest Outcomes Hall B-2 CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150 CVS.214 Sudden Cardiac Death: State of the Science Room D Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

11 CARDIOPULMONARY RESUSCITATION (cont.) Tuesday Nov 19 7:30-8:45 CVS.215 Atrial Fibrillation: State of the Science Room D167 ATE.405 How to Improve Leadership and Teamwork in Resuscitation Hall B-2 CVS.410 Joint AHA/Society for Cardiovascular Pathology and Association for European Cardiovascular Pathology Session: Sudden Cardiac Death in the Young with Structurally Normal Heart 9:00-5:00 APS Cardiac Arrest and Resuscitation Innovations Hall F, Core 4 Hall B-1 APS Clinical Studies of Cardiac Arrest and Resuscitation Hall F, Core 4 APS Epidemiology of Atrial Fibrillation and Sudden Cardiac Death Hall F, Core 2 2:00-3:15 CVS.412 Novel Strategies to Improve Outcome from Cardiac Arrest Hall B-3 3:45-5:00 CVS.219 Preparing Cardiac Patients and Families for End of Life Room D168 5:30-6:45 CVS.414 Practical Issues in Postarrest Therapeutic Hypothermia Hall B-2 CVS.415 Ventricular Fibrillation: From Bench to Bedside Hall B-4 Wednesday Nov 20 7:30-8:45 CVS.417 ECG Screening Programs for Prevention of Sudden Death: Benefits, Risks and Costs Hall B-3 CVS.525 Inflammation in Cardiac Disease and Remodeling Hall B-9 CVS.416 Management of Atrial Fibrillation in Difficult Populations Hall B-1 ATE.506 Management of VAD Complications Hall B-7 9:00-10:15 CVS.812ic Screening Considerations for Athletes: Balancing the Risks with Cost of Assessment Ballrooms C3&C4 CARDIOVASCULAR AND STROKE NURSING Saturday Nov 16 1:00-5:00 EC.05 Mechanisms and Models of Early Career Success in Cardiovascular and Stroke Nursing Science Room D168 (Planned by the Council on Cardiovascular and Stroke Nursing) Sunday Nov 17 8:00-11:00 SMP.402 Controversies in Hospital ECG Monitoring Hall B-3 SMP.203 Nursing Science in Review: Top Trials in Room D168 SMP.504 The Lost Souls of Heart Failure: Heart Failure with Preserved Ejection Fraction and Right-Heart Failure Hall B-8 SMP.304 Thrombosis, Antithrombotic Prophylaxis and Therapy in Pediatric Heart Disease Ballroom A1 9:00-5:00 APS Cardiovascular Disease in Diverse Populations Hall F, Core 2 APS Heart Disease in Children and Young Families Hall F, Core 2 APS Lifestyle and Behavioral RFs Hall F, Core 2 3:45-5:00 AOS YN Katharine A. Lembright Award/Lecture and Martha N. Hill New Investigator Award Finalists Room D162 4:00-5:19 LBCT.01 Acute Cardiovascular and Cerebrovascular Care Hall E 5:30-6:45 ATE.201 Achieving Accountability: How Will ACOs Impact the Delivery of Cardiovascular Care? Room D162 CVS.202 Is There Sex After Heart Disease? Room D168 CVS.301 New Therapies for Pediatric Heart Failure Ballroom A4 Monday Nov 18 7:30-8:45 CVS.205 Latest Nutrition Trials: Recent Progress and Shortcomings Room D167 ATE.503 Practical Issues in Heart Failure Readmissions: Stories from the Transition Trenches Hall B-9 ATE.402 Pro/Con: How Long Should We Continue Cardiac Arrest Resuscitation Efforts? Hall B-2 CVS.305 Risk Management of Pregnancy in the Adult Congenital Heart Disease Patient Ballroom A1 CVS.207 The Epidemic of Atrial Fibrillation: What's New for Non-EP Providers Room D168 Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

12 CARDIOVASCULAR AND STROKE NURSING (cont.) 9:00-10:15 ATE.202 Heart Tones/Brain Waves: The Body/Mind Connection Room D168 AOS N Stroke Council Award and Lecture and Prediction and Prognostication in Stroke: Clinical Aspects Room C144 AOS N William W. L. Glenn Lecture and Surgical Therapy for Valvular Heart Disease II Room D227 AOS Fascinatin Rhythms: Epidemiology of Atrial Fibrillation and Sudden Death Room D170 9:00-5:00 APS Arrhythmia Management Hall F, Core 4 APS Arrhythmia Mechanisms and Management Hall F, Core 4 APS Cancer and Cardiovascular Disease II Hall F, Core 2 APS Diagnostic Approaches in Heart Disease Hall F, Core 2 APS Heart Failure Disease Management Hall F, Core 2 APS Heart-Brain Interactions: Clinical Aspects Hall F, Core 7 10:45-12:00 AOS Approaches to Disease and Self-Management Room D168 SS.04 Stopping the No. 1 Killer of Women in the Second Decade of Go Red For Women Ballrooms C1&C2 2:00-3:15 AOS Symptoms and Symptom Management Room D168 3:45-5:00 CVS.209 Palliative Care and Congenital Heart Disease: Not Just at End of Life Room D168 5:30-6:45 CVS.610 Controversies in Heart Failure Surgery Room D222 CVS.307 Controversies in Postoperative Care Ballroom A4 CVS.509 Decision Making in Advanced Heart Failure Hall B-7 CVS.210 Racial/Ethnic Differences in Risks for Diabetes and Heart Disease: Implications for Diagnosis and Management Room D163 CVS.211 State of Exercise Science for Cardiovascular Health Promotion: Methods, Measures and Interventions Room D168 7:00-9:00 CVES.03 Atrial Fibrillation Management: Clinical Challenges Omni Dallas Hotel, Dallas Ballroom BC Tuesday Nov 19 7:30-8:45 ATE.405 How to Improve Leadership and Teamwork in Resuscitation Hall B-2 ATE.203 Symptom Recognition and CVD Room D168 9:00-10:15 CVS.218 Cognitive Dysfunction and Cardiovascular Disease: State of the Science Room D168 PS.05 Stroke Prevention in Atrial Fibrillation: New Options in 2013 Hall E 9:00-12:10 AOS Dilemmas in the Anticoagulation of Atrial Fibrillation Hall B-1 AOS Multidisciplinary Approaches to Arrhythmia Management Hall B-2 9:00-5:00 APS Cardiovascular Implications of Noncardiac Medications Hall F, Core 2 APS Clinical Cardiac Electrophysiology III Hall F, Core 4 APS Comorbidities in Cardiovasular Disease Hall F, Core 2 APS Depression and Stress in Heart Disease Hall F, Core 2 10:45-12:00 AOS Cognitive Function and Heart Failure Room D168 10:45-12:03 LBCT.05 New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis Hall E 2:00-3:15 AOS Strategies for Behavioral Change and Cardiovascular Risk Reduction Room D168 3:45-5:00 PS.07 Controversies in Heart Failure and the Answers Hall E CVS.219 Preparing Cardiac Patients and Families for End of Life Room D168 3:45-5:13 CS.03 Novel Approaches to Treating Hypertension and Atherosclerosis Ballrooms C1&C2 5:30-6:45 ATE.205 Appropriately Implementing Appropriateness Use Criteria in Clinical Practice Room D162 ATE.206 Bringing Interventions to Diverse and Vulnerable Populations Room D168 CVS.414 Practical Issues in Postarrest Therapeutic Hypothermia Hall B-2 80 Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

13 CARDIOVASCULAR AND STROKE NURSING (cont.) Wednesday Nov 20 7:30-8:45 CVS.725 Depression: Status as a Risk Factor in Acute Coronary Syndromes Room C144 CVS.615 Does It Make a Difference How You Think? Cardiovascular Disease and Cognition Room D222 ATE.207 Improving Patient Adherence to Treatment Recommendations Room D168 ATE.306 Infectious Diseases of the Heart: Updates on Old Problems Ballroom A1 CVS.317 The New Anticoagulants: Patient Education, Conversion, Management and Pharmacoeconomics Is It Worth It? Ballroom A2 9:00-10:25 AOS Symptoms and Disease Management in Heart Failure Room D168 9:00-12:00 APS Cardiovascular Disease: A Global Perspective Hall F, Core 2 APS Cardiovascular Risk Hall F, Core 2 APS Clinical Cardiac Electrophysiology IV Hall F, Core 4 APS h Clinical Cardiac Electrophysiology V Hall F, Core 4 APS What s New in Pacing Hall F, Core 4 CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENT Saturday Nov 16 1:00-2:40 EC.11 Mission Possible: Keys to Early Career Academic Success Part 1 Room C143 (Planned by the Council on Basic Cardiovascular Sciences) 3:00-4:45 EC.16 Mission Possible: Keys to Early Career Academic Success Part 2 Room C143 (Planned by the Council on Basic Cardiovascular Sciences) Sunday Nov 17 8:00-11:00 SMP.503 Epigenetics of Cardiac Development and Disease Hall B-6 SMP.403 Joint AHA/Cardiac Electrophysiology Society Session: Atrial Fibrillation Basic Mechanisms and Hall B-1 Clinical Treatment in 2013 SMP.502 Stem Cell Therapeutics Hall B-5 SMP.507 The Best of Circulation Research Symposium Hall B-2 8:00-11:30 SMP.501 The DeHaan Cardiac Myogenesis Initiative Room D223 9:00-5:00 APS h Biology of Cardiac Regeneration Hall F, Core 5 APS Controlling and Observing Stem Cell Behavior Hall F, Core 7 APS Extracellular Matrix Proteins and Cardiac Remodeling Hall F, Core 5 APS Femoropopliteal Artery Stenting; Restenosis Hall F, Core 7 APS h Molecular Regulation in Heart Failure Hall F, Core 3 APS Myocardial Infarction: Novel Mechanisms of Injury and Repair Hall F, Core 7 APS Oxidative Stress and Endothelial Function Hall F, Core 7 APS Progenitor Cells and Heart Development Hall F, Core 5 3:45-5:00 SS.01 Best of AHA Specialty Conferences Room C147 AOS Y Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators Finalists Hall B-5 5:15-6:30 AOS Y Melvin L. Marcus Young Investigator Award in Cardiovascular Sciences Finalists Hall B-5 5:30-6:45 CVS.502 Joint AHA/Progenitor Cell Biology Consortium Session: New Strategies for Myocardial Regeneration Clear Fork Room Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

14 CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENT (cont.) Monday Nov 18 7:30-8:45 CVS.505 Cardiac Aging and DNA Damage Hall B-7 9:00-12:00 AOS F Optimizing Stem Cell Repair in Models of Disease Room C146 9:00-12:10 AOS Epigenetic and Noncoding RNA Regulation in the Cardiovascular System Ballroom A2 9:00-5:00 APS Gene Regulatory Mechanisms in Heart Failure Hall F, Core 5 APS Regulators of Vascular Growth, Regeneration and Repair Hall F, Core 7 APS Reprogramming: Cell Biology Is Going Backwards Hall F, Core 5 APS h Stem Cells and Tissue Engineering for Regeneration Hall F, Core 7 BASC.05 Best of AHA Specialty Conferences: BCVS 2013 Hall F 2:00-5:10 AOS New Developments in Myocardial Pathology and Disease Hall B-9 2:00-5:15 LBS.01F Late-Breaking Basic Science and Featured Research Presentation Hall B-5 5:00-7:00 LBS.02 Late-Breaking Basic Science Posters and Reception Hall F APS Best of Basic Science Abstracts and Reception Hall F 5:30-6:45 CVS.513 Cardiomyocyte Renewal Hall B-5 Tuesday Nov 19 CVS.713 Emerging Paradigms in Progenitor Cell Therapy and Vascular Repair Room C143 CVS.408 Novel Approaches to the Study of Arrhythmias Hall B-1 CVS.512 The Emerging Roles of Cardiac Secretome: From Discovery to Mechanisms Hall B-9 CVS.711 Vascular Stem Cells and Smooth Muscle Plasticity Room C140 7:30-8:45 CVS.309 Epidemiology and Genetics of Adult Congenital Heart Disease: Insights from GenTAC, the National Registry of Genetically Triggered Aneurysms and Other Cardiovascular Conditions Ballroom A4 CVS.411 Genetics, Mechanism and Therapy of Conduction Block Hall B-4 CVS.107 Imaging in Potential Novel Therapies for Cardiovascular Diseases West Fork Room CVS.517 New Advances in Cardiac Systems Biology Hall B-7 9:00-12:00 AOS N George E. Brown Memorial Lecture and Adult Stem Cells: Cardiac Homeostasis and Repair Hall B-7 9:00-12:10 AOS Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure Hall B-5 AOS Optimizing Ways to Detect and Treat Ischemic Heart Disease Room C140 9:00-5:00 APS Myocardial Energetics/Intermediary Metabolism II Hall F, Core 5 APS Myocardial Response to Injury Hall F, Core 5 APS New Insights into Myocardial Structure and Pathology Hall F, Core 5 APS Translational and Clinical Studies of Cardiovascular Stem Cells Hall F, Core 7 2:00-5:10 AOS Developmental and Reactive Cardiomyocyte Growth Signaling Ballroom A2 AOS Molecular Mechanisms of Cardiac Arrhythmias Hall B-2 AOS Novel Mechanisms of Cardioprotection and Stem Cell Mediated Repair Hall B-6 5:30-6:45 CVS.723 How Are Mechanisms of Arteriogenesis Affected by Metabolic Syndrome and Diabetes? Room C144 CVS.518 ips Cells in Cardiac Disease Modeling Hall B-8 CVS.109 Myocardial Repair West Fork Room Wednesday Nov 20 7:30-8:45 CVS.523 Cardiac-Based Gene Therapies Hall B-5 9:00-12:00 APS Cellular Therapies for Heart Failure and Transplant Vasculopathy Hall F, Core 6 APS Novel Cellular Therapies for Heart Failure II Hall F, Core 5 APS Novel Strategies in Cardiac Regeneration and Repair Hall F, Core 5 9:00-12:10 AOS Mechanisms of Cardiomyocyte Death and Survival Hall B-8 AOS Molecular Signals in Vascular Development and Disease Room C Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

15 CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPAN Saturday Nov 16 1:00-3:00 EC.13 Choosing Your Path (Planned by the Council on Cardiovascular Disease in the Young) Room C144 Sunday Nov 17 8:00-11:00 SMP.204 Achieving the AHA s 2020 Strategic Impact Goals Room D163 SMP.401 Arrhythmogenic and Hypertrophic Cardiomyopathies: Scientific and Clinical Updates Hall B-4 SMP.402 Controversies in Hospital ECG Monitoring Hall B-3 SMP.103 Intervention Imaging Elm Fork Room SMP.303 New Genetic Tools in Congenital Heart Disease Ballroom A4 SMP.304 Thrombosis, Antithrombotic Prophylaxis and Therapy in Pediatric Heart Disease Ballroom A1 9:00-5:00 APS Basic Studies and Basic Care in HLHS Hall F, Core 3 APS Clinical and Hospital-Based Observational Studies Hall F, Core 2 APS Congenital Heart Disease: Miscellaneous Aspects Hall F, Core 3 APS Environment and Comorbid Conditions in CVD Hall F, Core 2 APS Heart Disease in Children and Young Families Hall F, Core 2 3:45-5:00 AOS Y CVDY Early Career Investigator Award Finalists Ballroom A1 5:30-6:45 ATE.401 Basic and Clinical Controversies in Brugada Syndrome Hall B-3 CVS.303 Genetics in Your Practice Ballroom A3 CVS.301 New Therapies for Pediatric Heart Failure Ballroom A4 CVS.304 Open Questions in Interventional Cardiology Ballroom A1 Monday Nov 18 7:30-8:45 ATE.403 Early Repolarization in My Patient: Should I Be Concerned? Hall B-1 CVS.305 Risk Management of Pregnancy in the Adult Congenital Heart Disease Patient Ballroom A1 ATE.303 Septating the Unbalanced Heart: Should We or Shouldn t We? Ballroom A4 9:00-10:28 LBCT.02 Prevention: From Schools to Countries Ballrooms C1&C2 9:00-11:55 AOS Still the One: Population Burden and Trends of CVD Room D162 9:00-12:10 AOS Adult Congenital Heart Disease: Morbidity and Mortality with and Without Intervention Ballroom A3 AOS Single-Ventricle Surgery: From Start to Fontan Ballroom A4 9:00-5:00 APS Echocardiography: Right Ventricular Function and Mechanics Hall F, Core 1 APS Pediatric Electrophysiology: Tachycardias, Pacing and Ablation Hall F, Core 3 APS Pediatric Heart Failure Hall F, Core 3 APS Pediatric Imaging: Ventricular Volume, Mass and Function Hall F, Core 3 10:45-12:00 SS.05 Contemporary Assessment of the Right Heart Room C147 2:00-3:15 SS.08 Success Story and Growing Challenge: Adult Congenital Heart Disease Ballrooms C3&C4 2:00-5:00 AOS F 3D Echocardiography of Heart Valve Anatomy and Intracardiac Flow Clear Fork Room 2:00-5:10 AOS New Developments in Myocardial Pathology and Disease Hall B-9 AOS Pediatric Heart Surgery: Perioperative Issues and Late Outcomes Ballroom A1 AOS Tachycardia: Basic and Applied; Lipids and Hypertension Ballroom A4 3:45-5:00 CVS.209 Palliative Care and Congenital Heart Disease: Not Just at End of Life Room D168 5:30-6:45 CVS.307 Controversies in Postoperative Care Ballroom A4 ATE.304 Improving ACHD Care Delivery Ballroom A1 CVS.408 Novel Approaches to the Study of Arrhythmias Hall B-1 Purchase Sessions OnDemand Premium today and save $200 in Lobby C and HeartQuarters Booth

16 CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPAN (cont.) Tuesday Nov 19 7:30-8:45 CVS.309 Epidemiology and Genetics of Adult Congenital Heart Disease: Insights from GenTAC, the National Registry of Genetically Triggered Aneurysms and Other Cardiovascular Conditions Ballroom A4 CVS.515 Heart Failure in the Patient with Adult Congenital Disease Hall B-9 CVS.410 Joint AHA/Society for Cardiovascular Pathology and Association for European Cardiovascular Pathology Session: Sudden Cardiac Death in the Young with Structurally Normal Heart Hall B-1 ATE.305 Risk Factor Control in Patients with Congenital Heart Disease Ballroom A1 7:30-8:45 CVS.310 The Heart in the Muscular Dystrophies Ballroom A3 9:00-11:00 MOC.03 Maintenance of Certification: Part 2 Credit Using the American Board of Pediatrics 2013 Pediatric Cardiology Subspecialty Self-Assessment Room C155 9:00-12:10 AOS Free Pulmonary Insufficiency and Other Daily Problems Ballroom A1 AOS Pediatric Heart Failure: Prognosis and Treatment from Infusion to Transplant Ballroom A4 AOS Physical Activity/Exercise Benefits: From Childhood to End-Stage Disease Room D163 9:00-5:00 APS D/4D Echocardiography Hall F, Core 1 APS Pediatric Cardiac Surgery: Peri- and Postoperative Issues Hall F, Core 3 APS Pediatric Hypertension and Lipids; Late Implications of Adult Congenital Heart Disease Hall F, Core 3 10:45-12:00 SS.18 Joint AHA/NEJM Session: Clinical Decisions Should Young Athletes Undergo Pre-Participation Cardiovascular Screening? Room C147 2:00-5:00 AOS N T. Duckett Jones Memorial Lecture, Best of CVDY and Aspects of Acquired Disease Ballroom A1 5:30-6:45 CVS.312 Familial Hypercholesterolemia: Challenges and Opportunities Ballroom A2 CVS.314 Hypoplastic Left-Heart Syndrome: How Far Have We Come? Ballroom A1 CVS.315 Technical Innovations in Pediatric Electrophysiology Ballroom A4 Wednesday Nov 20 7:30-8:45 CVS.318 Challenging Imaging Diagnoses: What Tools Are Available? Ballroom A4 CVS.417 ECG Screening Programs for Prevention of Sudden Death: Benefits, Risks and Costs Hall B-3 ATE.306 Infectious Diseases of the Heart: Updates on Old Problems Ballroom A1 CVS.616 PAD in Younger Patients (<40 Years of Age): Special Considerations Room D227 CVS.316 Pathogenesis of Autoimmune-Associated Heart Abnormalities: From Bench to Bedside Ballroom A3 9:00-12:00 APS Adult Congenital Heart Disease: Outcomes Hall F, Core 3 APS h Adult Congenital Heart Disease: Predictors of Outcome and Implications of Fontan Hall F, Core 3 9:00-12:10 AOS Autophagy, Mitochondria and Protein Homeostasis Hall B-5 AOS Molecular Signals in Vascular Development and Disease Room C146 AOS Pediatric Imaging: Function and Flow Ballroom A4 AOS Single-Ventricle Cardiology: Palliation, Care and Resource Utilization Ballroom A3 DIABETES, LIPIDS AND CARDIOMETABOLIC SYNDROME Saturday Nov 16 7:00-9:00 CVES.01 Diabetes and Cardiovascular Disease: Current Controversies Omni Dallas Hotel, Dallas Ballroom BC Sunday Nov 17 8:00-11:00 SMP.205 Clinical Lipidology: Controversies in Cardiovascular Risk Reduction Room D167 SMP.201 New Scientific Advances That Support Food-Based Dietary Recommendations Room D162 SMP.202 Novel Therapeutics and Strategies in Type 2 Diabetes and CVD Room D170 SMP.704 Obesity in CVD Room C140 SMP.301 Personalized Medicine: Pharmacogenomics and Metabolomics Is That Your Final Answer? Ballroom A3 SMP.701 The Inflammasome Pathway in Cardiovascular and Metabolic Disease Basic Science to Clinical Trials Room C Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine

Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine AHA Scientific Sessions Awards and Travel Grants Available by Abstract Category and Award applicants must have submitted an abstract to a category listed under that award and be a member of award s the

More information

List of Workshops Workshop Title

List of Workshops Workshop Title List of Workshops 2017 Year 2017 A CANADIAN HEART RHYTHM SOCIETY WORKSHOP: MANAGEMENT OF VENTRICULAR TACHYCARDIA 2017 CANADIAN SOCIETY OF CARDIOVASCULAR NUCLEAR AND CT IMAGING: CORONARY ATHEROSCLEROSIS

More information

Summary of Research and Writing Activities In Cardiovascular Disease

Summary of Research and Writing Activities In Cardiovascular Disease Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts

More information

ESC Congress Munich 2018

ESC Congress Munich 2018 ESC Congress Munich 2018 25-29 August Where the world of cardiology comes together Topic List European Society of Cardiology - Topic List 2018 1 Topic List Topic A Basics 3 Topic B Imaging 3 Topic C Arrhythmias

More information

European Society of Cardiology ESC CONGRESS 2019 TOPICS FOR ABSTRACT SUBMISSION

European Society of Cardiology ESC CONGRESS 2019 TOPICS FOR ABSTRACT SUBMISSION European Society of Cardiology ESC CONGRESS 2019 TOPICS FOR ABSTRACT SUBMISSION Topics At the time of abstract submission, the submitter must select one single topic to index the abstract. It is important

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

In Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison

In Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality

More information

ARRHYTHMIAS AND DEVICE THERAPY

ARRHYTHMIAS AND DEVICE THERAPY Topic List A BASICS 1 History of Cardiology 2 Clinical Skills 2.1 History Taking 2.2 Physical Examination 2.3 Electrocardiography 2.99 Clinical Skills - Other B IMAGING 3 Imaging 3.1 Echocardiography 3.2

More information

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

Preliminary Programme

Preliminary Programme Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management

More information

Adult Congenital Heart Disease Certification Examination Blueprint

Adult Congenital Heart Disease Certification Examination Blueprint Adult Congenital Heart Disease Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the

More information

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start? Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation

More information

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack AGENDA Friday, January 12 4:30 p.m. Registration at Westin Snowmass Conference Center 6:30 p.m. Saturday, January 13 3:30 p.m. Registration and Refreshment Break SESSION I Moderator: 4:00 p.m. Welcome

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from

More information

XXI Congress of the Cardiology Society of Serbia (CSS) Preliminary Programme Zlatibor, October, 2017

XXI Congress of the Cardiology Society of Serbia (CSS) Preliminary Programme Zlatibor, October, 2017 XXI Congress of the Cardiology Society of Serbia () Preliminary Programme Zlatibor, 19-22 October, 15.00 Interventional Cardiology in Serbia 15.15 15.30 15.45 16.00 16.15 at the Congress Thursday, October

More information

Timothy Malins, MD, FACC Governor, New York Chapter, American College of Cardiology President, New York Cardiological Society

Timothy Malins, MD, FACC Governor, New York Chapter, American College of Cardiology President, New York Cardiological Society New York Cardiovascular Symposium December 8-10, 2017 New York Hilton Midtown Thursday, December 7 2:30 p.m. - Registration Rhinelander (2 nd Floor) 6:30 p.m Friday, December 8 6:00 a.m. Registration Rhinelander

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

FOCUS ON CARDIOVASCULAR DISEASE

FOCUS ON CARDIOVASCULAR DISEASE The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

Arteriosclerosis & Atherosclerosis

Arteriosclerosis & Atherosclerosis Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)

More information

VIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC

VIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC Organised by the Heart Failure Association of the ESC HEART 2018 FAILURE including the 2 6-2 9 M AY VIENNA ADVANCE PROGRAMME www.escardio.org/heartfailure WELCOME Heart Failure is the world s leading congress

More information

Core Curriculum for the Cardiovascular Clinician

Core Curriculum for the Cardiovascular Clinician September 14 17, 2016 Heart House Washington, DC AGENDA Wednesday, September 14 PHARMACOLOGY WORKSHOP 5:30 p.m. Registration and Light Refreshments 6:00 p.m. Welcome and Introductions 6:15 p.m. CVD Guideline-driven

More information

When Should I Order a Stress Test or an Echocardiogram

When Should I Order a Stress Test or an Echocardiogram When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506

More information

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Dyslipidemia Endothelial dysfunction Free radicals Immunologic ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and

More information

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational Medical Knowledge Goals and Objectives PF EF MF LF Aspirational Know the basic principles of magnetic resonance imaging (MRI) including the role of the magnetic fields and gradient coil systems, generation

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN

8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN 8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN Mark your Calendar for July 26-29, 2018 to Attend the Only Available Comprehensive Review of Clinical Cardiology Practice designed for Nurse Practitioners

More information

Advance Programme ACUTE CARDIOVASCULAR CARE2015 EUROPEAN SOCIETY OF CARDIOLOGY

Advance Programme ACUTE CARDIOVASCULAR CARE2015 EUROPEAN SOCIETY OF CARDIOLOGY Advance Programme ACUTE CARDIOVASCULAR CARE2015 EUROPEAN SOCIETY OF CARDIOLOGY 08:30 10:00 Saturday 17 October 2015 Zeremoniensaal Prinz Eugen Saal Rittersaal Gartensaal Neurologic emergencies Acute cardiovascular

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives

More information

HEART CONDITIONS IN SPORT

HEART CONDITIONS IN SPORT HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One

More information

2015 Preliminary Agenda

2015 Preliminary Agenda 2015 Preliminary Agenda Revised 10/08/15 THURSDAY, NOVEMBER 12, 2015 PRE-COURSE WORKSHOP LEARNING OBJECTIVES: At the conclusion of this activity, participants will be better able to: 1. Identify subtle

More information

EAS Congress Innsbruck Highlights: A programme to excite, inspire and inform!

EAS Congress Innsbruck Highlights: A programme to excite, inspire and inform! Press release 84 th European Atherosclerosis Society Congress, Innsbruck, Austria For circulation 29 th May, 2016. 84 th Annual Congress of the European Atherosclerosis Society (EAS) May 29 th - June 1

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A AADs. See Antiarrhythmic drugs (AADs) ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors ACP in transseptal approach to

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic

More information

Advanced Heart Failure and Transplant Cardiology

Advanced Heart Failure and Transplant Cardiology Advanced Heart Failure and Transplant Cardiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills

More information

PATIENTS AND METHODS:

PATIENTS AND METHODS: BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

Exploring the Reno-Cardiac Connection. Protect your kidneys save your heart

Exploring the Reno-Cardiac Connection. Protect your kidneys save your heart Exploring the Reno-Cardiac Connection Protect your kidneys save your heart Heart Failure: a major health care problem ~23 million people with heart failure worldwide Heart failure increases progressively

More information

ASE 2011 Appropriate Use Criteria for Echocardiography

ASE 2011 Appropriate Use Criteria for Echocardiography ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Cardiac Computed Tomography

Cardiac Computed Tomography Cardiac Computed Tomography Authored and approved by Koen Nieman Stephan Achenbach Francesca Pugliese Bernard Cosyns Patrizio Lancellotti Anastasia Kitsiou Contents CARDIAC COMPUTED TOMOGRAPHY Page 1.

More information

University of Cincinnati Heart, Lung & Vascular Institute

University of Cincinnati Heart, Lung & Vascular Institute University of Cincinnati Heart, Lung & Vascular Institute The nucleus for research and discovery, patient-centered clinical care and academic excellence. University of Cincinnati Heart, Lung & Vascular

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

Sudden cardiac death: Primary and secondary prevention

Sudden cardiac death: Primary and secondary prevention Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)

More information

Cardiology/Cardiothoracic

Cardiology/Cardiothoracic Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00

More information

7th Congress of the Asia-Pacific Pediatric Cardiac Society

7th Congress of the Asia-Pacific Pediatric Cardiac Society 7th Congress of APPCS Wednesday, August 29, 2018 Thursday, August 30, 2018 Time Counter Ballroom 1 Ballroom 2 Ballroom 3 Junior Ballroom 2 Room 1 Room 2 Prefunction Area Level 1 07:00-07:30 08:00-20:00

More information

12 Lead EKG Chapter 4 Worksheet

12 Lead EKG Chapter 4 Worksheet Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining

More information

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

1. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study Hsieh, B.P., et al. Am

More information

Joint Congress PAFCIC Complex PCI meeting

Joint Congress PAFCIC Complex PCI meeting Joint Congress PAFCIC Complex PCI meeting October 18-20, 2018, Nairobi, KENYA The Program : - Interactive sessions - Practical workshops - Key note lectures - Live transmissions - Poster and oral presentations

More information

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained? TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific

More information

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Clinical Cardiac Electrophysiology

Clinical Cardiac Electrophysiology Clinical Cardiac Electrophysiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Management of Heart Failure in Adult with Congenital Heart Disease

Management of Heart Failure in Adult with Congenital Heart Disease Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars on the 3 rd Wednesday of each month to address topics related to risk adjustment

More information

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI) Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Evaluate common abnormalities that mimic myocardial infarction. Identify

More information

CARDIOLOGY. 3 To develop in the trainees the humanistic, moral and ethical aspects of medicine.

CARDIOLOGY. 3 To develop in the trainees the humanistic, moral and ethical aspects of medicine. CARDIOLOGY (I) OBJECTIVES 1 To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism required of a specialist in Cardiology. 2 To

More information

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute myocardial infarction contemporary DES platforms in patients with, 290 AF. See Atrial fibrillation (AF) African Americans dietary factors

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acidosis, electrolyte disturbances and, 641 Acute coronary syndrome, 547 557 antiplatelet therapy for, 565 adenosine diphosphate receptor

More information

The 54th Annual Meeting of The Society of Thoracic

The 54th Annual Meeting of The Society of Thoracic THE SOCIETY OF THORACIC SURGEONS: FIFTY-FOURTH ANNUAL MEETING The Society of Thoracic Surgeons 54th Annual Meeting January 27 31, 2018 Greater Fort Lauderdale/Broward County Convention Center, Fort Lauderdale,

More information

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD

More information

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 3/20 - B 3/21 - A 3/22 - B 3/23 - A 3/24 - B 3/27 - A Dissection Ethics Debate 3/28 - B 3/29 - A Intro to Cardiovascular

More information

The 2014 Louisville Symposium on Heart Disease in Women: Update on Treatment and Prevention. Saturday, June 28th

The 2014 Louisville Symposium on Heart Disease in Women: Update on Treatment and Prevention. Saturday, June 28th Program Details The Louisville Symposium on Heart Disease in Women: Update on Treatment and Prevention is a oneday conference to address current guidelines and trends in the field of cardiovascular medicine

More information

Course Learning Objectives Sunday, February 17 Friday, February 22

Course Learning Objectives Sunday, February 17 Friday, February 22 Course Learning Objectives Sunday, February 17 Friday, February 22 1. Define the physical principles of ultrasound technology and its applications for two and threedimensional (2D, 3D) imaging and use

More information

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Rotation: or: Faculty: Coronary Care Unit (CVICU) Dr. Jeff Rottman Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg Duty Hours: Mon Fri, 7 AM to 7 PM, weekend call shared with consult

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama

Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama Congress Chairman Uri Elkayam, MD Professor of Medicine University of Southern California, Keck School of Medicine

More information

03/07/ Background. + High Risk Features Are Prevalent in Dialysis Patients

03/07/ Background. + High Risk Features Are Prevalent in Dialysis Patients + When Does Cardiovascular Disease Preclude Consideration of Renal Transplantation? Kul Aggarwal, MD, MRCP (UK), FACC Professor of Clinical Medicine Division of Cardiology University of Missouri & Chief,

More information

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Ischaemic heart disease. IInd Chair and Clinic of Cardiology Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery

More information

Anatomy of the Heart and the. ICD-10 Codes

Anatomy of the Heart and the. ICD-10 Codes Anatomy of the Heart and the Diseases ICD-10 Codes Sharon J. Oliver CPC, CPMA, CPC-I All Rights Reserved 1 Anatomy of the Heart Pulmonary Tricuspid (AV) Valve Mitral Aortic Semilunar Valve Chordae Tendineae

More information

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac

More information

Cardiovascular Evaluation in Preparation for Renal Transplantation

Cardiovascular Evaluation in Preparation for Renal Transplantation + Cardiovascular Evaluation in Preparation for Renal Transplantation Kul Aggarwal, MD, MRCP (UK), FACC Professor of Clinical Medicine Division of Cardiology University of Missouri & Chief, Cardiology Section

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Cardiovascular System and Health. Chapter 15

Cardiovascular System and Health. Chapter 15 Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer

More information